FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claire Verschraegen

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Hugo Arias-Pulido; Melanie Royce; Yun Gong; Nancy E Joste; Lesley Lomo; Sang-Joon Lee; Nabila Chaher; Claire F Verschraegen; Juanita Lara; Eric R Prossnitz; Massimo Cristofanilli
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.
Hugo Arias-Pulido; Harriet O Smith; Nancy E Joste; Therese Bocklage; Clifford R Qualls; Allison Chavez; Eric R Prossnitz; Claire F Verschraegen
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Harriet O Smith; Hugo Arias-Pulido; Dennis Kuo; Tamara Howard; Clifford R Qualls; Sang-Joon Lee; Claire F Verschraegen; Helen J Hathaway; Nancy E Joste; Eric R Prossnitz
GPR30 predicts poor survival for ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claire Verschraegen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Hugo Arias-Pulido; Melanie Royce; Yun Gong; Nancy E Joste; Lesley Lomo; Sang-Joon Lee; Nabila Chaher; Claire F Verschraegen; Juanita Lara; Eric R Prossnitz; Massimo Cristofanilli
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.
Breast cancer research and treatment 2010;123(1):51-8.
2009: Hugo Arias-Pulido; Harriet O Smith; Nancy E Joste; Therese Bocklage; Clifford R Qualls; Allison Chavez; Eric R Prossnitz; Claire F Verschraegen
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Gynecologic oncology 2009;114(3):480-5.
2009: Harriet O Smith; Hugo Arias-Pulido; Dennis Kuo; Tamara Howard; Clifford R Qualls; Sang-Joon Lee; Claire F Verschraegen; Helen J Hathaway; Nancy E Joste; Eric R Prossnitz
GPR30 predicts poor survival for ovarian cancer.
Gynecologic oncology 2009;114(3):465-71.
2009: Claire F Verschraegen; Keith Skubitz; Adil Daud; Andrzej P Kudelka; Ian Rabinowitz; Cecilia Allievi; Amy Eisenfeld; jack w singer; Fred B Oldham
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;63(5):903-10.
2008: S-J Lee; M Gounder; E H Rubin; Jong Ming Li; Zheming Gu; A Thalasila; Evelyne M Loyer; A P Kudelka; Claire F Verschraegen
Optimal modeling for phase I design of a two drug combination-results of a phase I study of cisplatin with 9-nitrocamptothecin.
Investigational new drugs 2008;26(6):541-51.
2008: Alonso V Pacheco; Kanwaldeep Rasila; Sang-Joon Lee; Ian Rabinowitz; Laurence Elias; Fa-Chyi Lee; Claire F Verschraegen
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols.
Urologic oncology 2008;26(6):610-5.
2008: George R Simon; Claire F Verschraegen; Pasi A Janne; Corey J Langer; Afshin Dowlati; Shirish M Gadgeel; Karen Kelly; Gregory P Kalemkerian; Anne M Traynor; Guangbin Peng; John Gill; Coleman K Obasaju; Hedy L Kindler
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(21):3567-72.
2008: David A Mills; Houman M Fekrazad; Claire F Verschraegen
SNS-595, a naphthyridine cell cycle inhibitor and stimulator of apoptosis for the treatment of cancers.
Current opinion in investigational drugs (London, England : 2000) 2008;9(6):647-57.
2006: Harriet O Smith; Charles Wiggins; Claire F Verschraegen; Laurence W Cole; Heather M Greene; Carolyn Y Muller; Clifford R Qualls
Changing trends in gestational trophoblastic disease.
The Journal of reproductive medicine 2006;51(10):777-84.
2006: Judith K Wolf; Diane C Bodurka; Claire F Verschraegen; Charlotte C Sun; Donna Branham; Alfred D Jenkins; Neely Atkinson; David M Gershenson
A phase II trial of oral capecitabine in patients with platinum--and taxane--refractory ovarian, fallopian tube, or peritoneal cancer.
Gynecologic oncology 2006;102(3):468-74.
2006: Claire F Verschraegen; vincent vinh-hung
Effects of radiotherapy and surgery for early breast cancer.
Lancet 2006;367(9523):1654; author reply 1654-5.
2006: Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Incidence and survival rates for female malignant germ cell tumors.
Obstetrics and gynecology 2006;107(5):1075-85.
2005: Hamid Sayar; Catherine Lhomme; Claire F Verschraegen
Malignant adnexal masses in pregnancy.
Obstetrics and gynecology clinics of North America 2005;32(4):569-93.
2005: Kanwaldeep Kaur Rasila; R A Burger; Harriet O Smith; Fa-Chyi Lee; Claire F Verschraegen
Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(5):710-26.
2005: Kanwaldeep Kaur Rasila; Claire F Verschraegen
Tasidotin HCl (Genzyme).
Current opinion in investigational drugs (London, England : 2000) 2005;6(6):631-8.
2005: Ursa Glaberman; Ian Rabinowitz; Claire F Verschraegen
Alternative administration of camptothecin analogues.
Expert opinion on drug delivery 2005;2(2):323-33.
2005: Claire F Verschraegen; vincent vinh-hung; Gábor Cserni; Richard Gordon; Melanie Royce; Georges Vlastos; Patricia Tai; Guy Storme
Modeling the effect of tumor size in early breast cancer.
Annals of surgery 2005;241(2):309-18.
2005: Wei Hu; John J Kavanagh; Michael Deaver; Dennis A Johnston; Ralph S Freedman; Claire F Verschraegen; Subrata Sen
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Oncology research 2005;15(1):49-57.
2004: Claire F Verschraegen; Harriet O Smith; Fa-Chyi Lee; Cynthia Cathcart; Jeffrey P Norenberg
TLK-286.
IDrugs : the investigational drugs journal 2004;7(8):771-81.
2004: Claire F Verschraegen; vincent vinh-hung
Re: Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.
Journal of the National Cancer Institute 2004;96(14):1111-2.
2004: Harriet O Smith; Clifford R Qualls; Robert D Hilgers; Claire F Verschraegen; William F Rayburn; Laurence W Cole; Luis A Padilla; Charles R Key
Gestational trophoblastic neoplasia in American Indians.
The Journal of reproductive medicine 2004;49(7):535-44.
2004: Claire F Verschraegen; Brian E Gilbert; Evelyne M Loyer; Armando Huaringa; Garrett Walsh; Robert A Newman; Vernon Knight
Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2319-26.
2004: vincent vinh-hung; Claire F Verschraegen
Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality.
Journal of the National Cancer Institute 2004;96(2):115-21.
2004: vincent vinh-hung; Claire F Verschraegen; Donald I Promish; Gábor Cserni; Jan Van de Steene; Patricia Tai; Georges Vlastos; Mia Voordeckers; Guy Storme; Melanie Royce
Ratios of involved nodes in early breast cancer.
Breast cancer research : BCR 2004;6(6):R680-8.
2004: Claire F Verschraegen; Andrzej P Kudelka; Wei Hu; Monique Vincent; John J Kavanagh; Evelyne M Loyer; Luc Bastien; A Duggal; Robert L De Jager
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
Cancer chemotherapy and pharmacology 2004;53(1):1-7.
2003: Ralph S Freedman; Saroj Vadhan-Raj; Cherie Butts; Cherylyn A Savary; Bohuslav Melichar; Claire F Verschraegen; John J Kavanagh; Marshall E Hicks; Lawrence B Levy; Jody Folloder; Michael E Garcia
Pilot study of Flt3 ligand comparing intraperitoneal with subcutaneous routes on hematologic and immunologic responses in patients with peritoneal carcinomatosis and mesotheliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5228-37.
2003: Wei Hu; WeiGuo Wu; Claire F Verschraegen; Ling Chen; Li Mao; Sai-Ching Jim Yeung; Andrzej P Kudelka; Ralph S Freedman; John J Kavanagh
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
Proteomics 2003;3(10):1904-11.
2003: Claire F Verschraegen; S Kumagai; R Davidson; B Feig; P Mansfield; S J Lee; DS Maclean; W Hu; Abdul R Khokhar; Zahid H Siddik
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
Journal of cancer research and clinical oncology 2003;129(10):549-55.
2003: Claire F Verschraegen; Silke Westphalen; Wei Hu; Evelyne M Loyer; Andrzej P Kudelka; Peter Völker; John Kavanagh; Melissa Steger; Klaus-Dieter Schulz; Günter Emons
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
Gynecologic oncology 2003;90(3):552-9.
2003: Günter Emons; Carsten Gründker; Andreas R Günthert; Silke Westphalen; John Kavanagh; Claire F Verschraegen
GnRH antagonists in the treatment of gynecological and breast cancers.
Endocrine-related cancer 2003;10(2):291-9.
2003: Harmeet Kaur; Paul M Silverman; Revathy B Iyer; Claire F Verschraegen; Patricia J Eifel; Chusilp Charnsangavej
Diagnosis, staging, and surveillance of cervical carcinoma.
AJR. American journal of roentgenology 2003;180(6):1621-31.
2003: Claire F Verschraegen; Wei Hu; Yu Du; John Mendoza; Janet Early; Michael Deavers; Ralph S Freedman; Robert C Bast; Andrzej P Kudelka; John J Kavanagh; Beppino C Giovanella
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):845-52.
2003: Duc Thanh Le; Michael Deavers; Kelly Hunt; Anais Malpica; Claire F Verschraegen
Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma.
Cancer investigation 2003;21(5):682-9.
2002: Renato Lenzi; Michael Rosenblum; Claire F Verschraegen; Andrzej P Kudelka; John J Kavanagh; Marshall E Hicks; Eric A Lang; Michael A Nash; Lawrence B Levy; Michael E Garcia; Chris D Platsoucas; James L Abbruzzese; Ralph S Freedman
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3686-95.
2002: Saroj Vadhan-Raj; John J Kavanagh; Ralph S Freedman; Jody Folloder; Laura M Currie; Carlos E Bueso-Ramos; Claire F Verschraegen; Aida Narvios; Jerome Connor; W Keith Hoots; Lyle D Broemeling; Benjamin Lichtiger
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Lancet 2002;359(9324):2145-52.
2002: Claire F Verschraegen
Irinotecan for the treatment of cervical cancer.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):32-4.
2002: Wei Hu; Weiguo Wu; Sai-Ching Jim Yeung; Ralph S Freedman; John J Kavanagh; Claire F Verschraegen
Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor.
Anticancer research 2002;22(2A):665-72.
2002: Wei Hu; Claire F Verschraegen; WG Wu; M Nash; Ralph S Freedman; Andrzej P Kudelka; John J Kavanagh
Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(2):202-7.
2001: Claire F Verschraegen; John J Kavanagh; Evelyne M Loyer; DC Bodurka-Bevers; Andrzej P Kudelka; W Hu; M Vincent; T Nelson; Charles Levenback
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
Cancer 2001;92(9):2327-33.
2001: Claire F Verschraegen
Intracavitary therapies for mesothelioma.
Current treatment options in oncology 2001;2(5):385-94.
2001: E Zavadova; Cherylyn A Savary; Stacie Templin; Claire F Verschraegen; Ralph S Freedman
Maturation of dendritic cells from ovarian cancer patients.
Cancer chemotherapy and pharmacology 2001;48(4):289-96.
2001: Claire F Verschraegen; M Benjapibal; W Supakarapongkul; Lawrence B Levy; Merrick Ross; E Neely Atkinson; DC Bodurka-Bevers; John J Kavanagh; Andrzej P Kudelka; Sewa S Legha
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(5):359-64.
2001: S Koonsaeng; Claire F Verschraegen; R Freedman; M Bossens; Andrzej P Kudelka; John Kavanagh; T Sittisomwong; E DeClercq; R Snoeck
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
Journal of medical virology 2001;64(2):195-8.
2001: P Azevedo; Claire F Verschraegen; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; K Lu; M T Deavers
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
European journal of gynaecological oncology 2001;22(5):319-21.
2000: C Moon; Claire F Verschraegen; M Bevers; R Freedman; Andrzej P Kudelka; John J Kavanagh
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Anti-cancer drugs 2000;11(7):565-8.
2000: Claire F Verschraegen; T Sittisomwong; Andrzej P Kudelka; E d Guedes; Melissa Steger; T Nelson-Taylor; Monique Vincent; R Rogers; E Neely Atkinson; John J Kavanagh
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2733-9.
2000: Ralph S Freedman; Andrzej P Kudelka; John J Kavanagh; Claire F Verschraegen; Creighton L Edwards; M Nash; L Levy; E Neely Atkinson; Hua-Zhong Zhang; Bohuslav Melichar; Rebecca Patenia; Stacie Templin; W Scott; Chris D Platsoucas
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2268-78.
2000: Saroj Vadhan-Raj; Claire F Verschraegen; Carlos E Bueso-Ramos; Hal E Broxmeyer; A P Kudelkà; Ralph S Freedman; Creighton L Edwards; David M Gershenson; Denny Jones; Mark Ashby; John J Kavanagh
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer.
Annals of internal medicine 2000;132(5):364-8.
2000: Wei Hu; Weiguo Wu; Michael A Nash; Ralph S Freedman; John J Kavanagh; Claire F Verschraegen
Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Anticancer research 2000;20(2A):729-33.
2000: Wei Hu; Pierre D McCrea; Michael Deavers; John J Kavanagh; Andrzej P Kudelka; Claire F Verschraegen
Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.
Clinical & experimental metastasis 2000;18(1):83-8.
2000: Claire F Verschraegen; Brian E Gilbert; Armando Huaringa; R Newman; Nick Harris; FJ Leyva; Leendert Keus; K Campbell; T Nelson-Taylor; Vernon Knight
Feasibility, phase I, and pharmacological study of aerosolized liposomal 9-nitro-20(S)-camptothecin in patients with advanced malignancies in the lungs.
Annals of the New York Academy of Sciences 2000;922():352-4.
2000: Claire F Verschraegen; Charles Levenback; Monique Vincent; J Wolf; Michael W Bevers; Evelyne M Loyer; Andrzej P Kudelka; John J Kavanagh
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan.
Annals of the New York Academy of Sciences 2000;922():349-51.
2000: Claire F Verschraegen; Monique Vincent; James L Abbruzzese; D Siegler; John J Kavanagh; Evelyne M Loyer; Andrzej P Kudelka; E Rubin
Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.
Annals of the New York Academy of Sciences 2000;922():345-8.
2000: Claire F Verschraegen; Kurt A Jaeckle; Beppino C Giovanella; Vernon Knight; Brian E Gilbert
Alternative administration of camptothecin analogues.
Annals of the New York Academy of Sciences 2000;922():237-46.
2000: Ozcan Balat; Creighton L Edwards; Claire F Verschraegen; L Delclos
The long term results of radiotherapy with or without surgery in management of advanced vulvar cancer: report of 76 patients.
European journal of gynaecological oncology 2000;21(4):426-9.
2000: T Sittisomwong; A Suneja; Andrzej P Kudelka; Claire F Verschraegen; John J Kavanagh
Estrogen replacement therapy and ovarian cancer.
European journal of gynaecological oncology 2000;21(4):348-54.
1999: Michael G Rosenblum; Claire F Verschraegen; James L Murray; Andrzej P Kudelka; Jacalyn B Gano; Lawrence Cheung; John J Kavanagh
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):953-61.
1999: Claire F Verschraegen; E Gupta; Evelyne M Loyer; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; Creighton L Edwards; Nick Harris; Melissa Steger; V Steltz; Beppino C Giovanella; John S Stehlin
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
Anti-cancer drugs 1999;10(4):375-83.
1999: Claire F Verschraegen; Creighton L Edwards; H Fox
Present knowledge of gynecologic sarcoma management.
Hematology/oncology clinics of North America 1999;13(1):211-23, x.
1999: E Zavadova; AE Loercher; S Verstovsek; Claire F Verschraegen; M Micksche; Ralph S Freedman
The role of macrophages in antitumor defense of patients with ovarian cancer.
Hematology/oncology clinics of North America 1999;13(1):135-44, ix.
1998: Bohuslav Melichar; G Ferrandina; Claire F Verschraegen; AE Loercher; James L Abbruzzese; Ralph S Freedman
Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell lines.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3069-76.
1998: Zia Rahman; John Kavanagh; Richard Champlin; R Giles; EG Hanania; S Fu; Z Zu; RC Mehra; Frankie A Holmes; Andrzej P Kudelka; David F Claxton; Claire F Verschraegen; James L Gajewski; Michael Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; Eugene Mechetner; Tatyana A Holzmayer; A Dayne; J Hamer; CR Bachier; J Ostrove; Albert Deisseroth
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2717-21.
1998: Andrzej P Kudelka; A Vasuratna; Creighton L Edwards; K Augustine; M Benjapibal; Claire F Verschraegen; John J Kavanagh
Gemcitabine after bone marrow transplantation for refractory juvenile granulosa cell tumor.
Anti-cancer drugs 1998;9(7):621-3.
1998: John J Kavanagh; Claire F Verschraegen; Andrzej P Kudelka
Irinotecan in cervical cancer.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):94-8.
1998: M Benjapibal; Andrzej P Kudelka; A Vasuratna; Creighton L Edwards; Claire F Verschraegen; V Valero; Saroj Vadhan-Raj; John J Kavanagh
Docetaxel and cyclophosphamide induced remission in platinum and paclitaxel refractory ovarian cancer.
Anti-cancer drugs 1998;9(6):577-9.
1998: Claire F Verschraegen; A Vasuratna; C Edwards; R Freedman; Andrzej P Kudelka; Carmen Tornos; John J Kavanagh
Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience.
Oncology reports 1998;5(4):939-44.
1998: Andrzej P Kudelka; Annette Hasenburg; Claire F Verschraegen; Creighton L Edwards; Christina A Meyers; D Varma; Ralph S Freedman; Arthur Forman; Charles A Conrad; W Grove; Axel Grothey; John J Kavanagh
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma.
Anti-cancer drugs 1998;9(5):405-9.
1998: Michael A Nash; Renato Lenzi; Creighton L Edwards; John J Kavanagh; Andrzej P Kudelka; Claire F Verschraegen; Chris D Platsoucas; Ralph S Freedman
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Clinical and experimental immunology 1998;112(2):172-80.
1998: A Vasuratna; Andrzej P Kudelka; Creighton L Edwards; V Wootipoom; Claire F Verschraegen; C Charnsangavej; John J Kavanagh
Prolonged remission of endometrial cancer with paclitaxel and carboplatin.
Anti-cancer drugs 1998;9(3):283-5.
1998: Bohuslav Melichar; Cherylyn A Savary; Andrzej P Kudelka; Claire F Verschraegen; John J Kavanagh; Creighton L Edwards; Chris D Platsoucas; Ralph S Freedman
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):799-809.
1998: Claire F Verschraegen; E A Natelson; Beppino C Giovanella; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; Creighton L Edwards; K Ende; John S Stehlin
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor.
Anti-cancer drugs 1998;9(1):36-44.
1997: G Ferrandina; Bohuslav Melichar; AE Loercher; Claire F Verschraegen; Andrzej P Kudelka; Creighton L Edwards; G Scambia; John J Kavanagh; James L Abbruzzese; Ralph S Freedman
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Cancer research 1997;57(19):4309-15.
1997: Andrzej P Kudelka; T Levy; Claire F Verschraegen; Creighton L Edwards; S Piamsomboon; Wichai Termrungruanglert; Ralph S Freedman; Alan L Kaplan; Dirk G Kieback; Christina A Meyers; Kurt A Jaeckle; Evelyne M Loyer; Melissa Steger; RP Mante; Giora Mavligit; A Killian; R A Tang; Jordan U Gutterman; John J Kavanagh
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1501-5.
1997: Koen van Besien; Claire F Verschraegen; R Mehra; Sergio Giralt; Andrzej P Kudelka; Creighton L Edwards; S Piamsonboom; Wichai Termrungruanglert; Richard Champlin; John J Kavanagh
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Gynecologic oncology 1997;65(2):366-9.
1997: Wichai Termrungruanglert; Andrzej P Kudelka; Creighton L Edwards; L Delclos; Claire F Verschraegen; John J Kavanagh
Gynecologic cancer in the elderly.
Clinics in geriatric medicine 1997;13(2):363-79.
1997: A A Ashour; Claire F Verschraegen; Andrzej P Kudelka; John J Kavanagh
Paraneoplastic syndromes of gynecologic neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1272-82.
1997: Claire F Verschraegen; T Levy; Andrzej P Kudelka; E Llerena; K Ende; Ralph S Freedman; Creighton L Edwards; M Hord; Melissa Steger; Alan L Kaplan; Dirk G Kieback; Ami Fishman; John J Kavanagh
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):625-31.
1997: S Piamsomboon; Andrzej P Kudelka; Wichai Termrungruanglert; Koen van Besien; Creighton L Edwards; S Lifshitz; D F Schomer; Richard Champlin; RP Mante; John J Kavanagh; Claire F Verschraegen
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
European journal of gynaecological oncology 1997;18(6):453-6.
1997: Ozcan Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report and review of literature.
European journal of gynaecological oncology 1997;18(5):341-2.
1997: J Herrada; Andrzej P Kudelka; Carmen Tornos; Dong M Shin; J J Kavanagh; Creighton L Edwards; Claire F Verschraegen
Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
European journal of gynaecological oncology 1997;18(1):39-41.
1996: E A Natelson; Beppino C Giovanella; Claire F Verschraegen; K M Fehir; P D De Ipolyi; N Harris; John S Stehlin
Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents.
Annals of the New York Academy of Sciences 1996;803():224-30.
1996: Andrzej P Kudelka; Wichai Termrungruanglert; S Vadhan-Raj; Creighton L Edwards; D G Varma; Carmen Tornos; Claire F Verschraegen; John J Kavanagh
Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel.
Anti-cancer drugs 1996;7(8):885-9.
1996: S Piamsomboon; Wichai Termrungruanglert; Andrzej P Kudelka; Creighton L Edwards; Ralph S Freedman; C F Mountain; L Delclos; M S Aapro; L DeCaro; J Bianca; Claire F Verschraegen; John J Kavanagh
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
Anti-cancer drugs 1996;7(7):800-4.
1996: Claire F Verschraegen; Andrzej P Kudelka; Wichai Termrungruanglert; C G de Leon; Creighton L Edwards; Ralph S Freedman; John J Kavanagh; S Vadhan-Raj
Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1609-11.
1996: Wichai Termrungruanglert; Andrzej P Kudelka; S Piamsomboon; Claire F Verschraegen; Creighton L Edwards; S Lifshitz; R P Mante; John J Kavanagh
Remission of refractory gestational trophoblastic disease with high-dose paclitaxel.
Anti-cancer drugs 1996;7(5):503-6.
1996: Andrzej P Kudelka; Claire F Verschraegen; Tally Levy; Creighton L Edwards; Ami Fishman; Ralph S Freedman; A Kaplan; Dirk G Kieback; R Mante; K Ende; Melissa Steger; John J Kavanagh
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
Anti-cancer drugs 1996;7(4):398-401.
1996: John J Kavanagh; Andrzej P Kudelka; C G de Leon; Damras Tresukosol; M Hord; M B Finnegan; E Edmund Kim; D Varma; A Forman; P Cohen; Creighton L Edwards; Ralph S Freedman; Claire F Verschraegen
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):837-42.
1996: Andrzej P Kudelka; Damras Tresukosol; Creighton L Edwards; Ralph S Freedman; Charles Levenback; P Chantarawiroj; C Gonzalez de Leon; E Edmund Kim; Timothy Madden; B Wallin; M Hord; Claire F Verschraegen; Martin N Raber; John J Kavanagh
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1552-7.
1996: Wichai Termrungruanglert; Andrzej P Kudelka; S Piamsomboon; Creighton L Edwards; Claire F Verschraegen; Evelyne M Loyer; John J Kavanagh
Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature.
European journal of gynaecological oncology 1996;17(6):493-6.
1996: Y C Lin; Andrzej P Kudelka; D Lawrence; Claire F Verschraegen; John J Kavanagh; Creighton L Edwards; R Mante; Ralph S Freedman
Transcatheter arterial embolization for the control of life-threatening pelvic hemorrhage in a patient with locally advanced cervix carcinoma.
European journal of gynaecological oncology 1996;17(6):480-3.
1996: O Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Remission of recurrent mixed germ cell tumor of the ovary after treatment with vincristine, carboplatin, fluorouracil, and ifosfamide: a case report and review of the literature.
European journal of gynaecological oncology 1996;17(5):342-4.
1996: O Balat; A Balat; Claire F Verschraegen; C Tornos; Creighton L Edwards
Sarcoma botryoides of the uterine endocervix: long-term results of conservative surgery.
European journal of gynaecological oncology 1996;17(5):335-7.
1996: O Balat; Claire F Verschraegen; Creighton L Edwards; E Silva; Andrzej P Kudelka; John J Kavanagh
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
European journal of gynaecological oncology 1996;17(4):271-3.
1996: O Balat; Andrzej P Kudelka; J C Tunca; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Prolonged stabilization of progressive platinum-refractory ovarian cancer with paclitaxel: brief report.
European journal of gynaecological oncology 1996;17(4):264-6.
1996: O Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; R Mante; John J Kavanagh
A case report of paclitaxel administered to a patient with platinum-refractory ovarian cancer on long-term hemodialysis.
European journal of gynaecological oncology 1996;17(3):232-3.
1995: Claire F Verschraegen; Charles A Conrad; Waun Ki Hong
Subacute encephalopathic toxicity of cisplatin.
Lung cancer (Amsterdam, Netherlands) 1995;13(3):305-9.
1995: Claire F Verschraegen; J T Mendoza; A J Kozielski; Beppino C Giovanella
Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouse.
Anticancer research 1995;15(1):9-11.
1991: Claire F Verschraegen; Beppino C Giovanella; J T Mendoza; A J Kozielski; John S Stehlin
Specific organ metastases of human melanoma cells injected into the arterial circulation of nude mice.
Anticancer research 1991;11(2):529-35.